327 related articles for article (PubMed ID: 27499538)
1. Hypersensitivity and immunologic reactions to biologics: opportunities for the allergist.
Khan DA
Ann Allergy Asthma Immunol; 2016 Aug; 117(2):115-20. PubMed ID: 27499538
[TBL] [Abstract][Full Text] [Related]
2. Rituximab Hypersensitivity: Evaluation, Desensitization, and Potential Mechanisms.
Wong JT; Long A
J Allergy Clin Immunol Pract; 2017; 5(6):1564-1571. PubMed ID: 29122155
[TBL] [Abstract][Full Text] [Related]
3. Adverse Reactions to Biologic Therapy.
Patel SV; Khan DA
Immunol Allergy Clin North Am; 2017 May; 37(2):397-412. PubMed ID: 28366484
[TBL] [Abstract][Full Text] [Related]
4. Anaphylaxis to chemotherapy and monoclonal antibodies.
Castells MC
Immunol Allergy Clin North Am; 2015 May; 35(2):335-48. PubMed ID: 25841555
[TBL] [Abstract][Full Text] [Related]
5. Utilizing Biologics in Drug Desensitization.
Yang BC; Castells MC
Curr Allergy Asthma Rep; 2023 Jan; 23(1):1-11. PubMed ID: 36445652
[TBL] [Abstract][Full Text] [Related]
6. Hypersensitivity reactions and anaphylaxis to checkpoint inhibitor-monoclonal antibodies and desensitization.
Labella M; Castells M
Ann Allergy Asthma Immunol; 2021 Jun; 126(6):623-629. PubMed ID: 33781937
[TBL] [Abstract][Full Text] [Related]
7. Immune-Related Adverse Drug Reactions and Immunologically Mediated Drug Hypersensitivity.
Macy E
Immunol Allergy Clin North Am; 2020 Nov; 40(4):635-647. PubMed ID: 33012325
[TBL] [Abstract][Full Text] [Related]
8. Rapid Drug Desensitization with Biologics: A Single-Center Experience with Four Biologics.
Bavbek S; Kendirlinan R; Çerçi P; Altıner S; Soyyiğit Ş; Çelebi Sözener Z; Aydın Ö; Gümüşburun R
Int Arch Allergy Immunol; 2016; 171(3-4):227-233. PubMed ID: 28049204
[TBL] [Abstract][Full Text] [Related]
9. Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment.
Brennan PJ; Rodriguez Bouza T; Hsu FI; Sloane DE; Castells MC
J Allergy Clin Immunol; 2009 Dec; 124(6):1259-66. PubMed ID: 19910036
[TBL] [Abstract][Full Text] [Related]
10. Hypersensitivity reactions during treatment with biological agents.
Puxeddu I; Caltran E; Rocchi V; Del Corso I; Tavoni A; Migliorini P
Clin Exp Rheumatol; 2016; 34(1):129-32. PubMed ID: 26751942
[TBL] [Abstract][Full Text] [Related]
11. How to manage hypersensitivity reactions to biological agents?
Barbaud A; Granel F; Waton J; Poreaux C
Eur J Dermatol; 2011; 21(5):667-74. PubMed ID: 21742594
[TBL] [Abstract][Full Text] [Related]
12. Anaphylactic reactions to biological drugs.
Matucci A; Vultaggio A; Nencini F; Maggi E
Curr Opin Allergy Clin Immunol; 2020 Aug; 20(4):346-351. PubMed ID: 32590502
[TBL] [Abstract][Full Text] [Related]
13. Desensitization for Allergic Reactions to Chemotherapy.
Hong DIC
Yonsei Med J; 2019 Feb; 60(2):119-125. PubMed ID: 30666832
[TBL] [Abstract][Full Text] [Related]
14. Omalizumab and hypersensitivity reactions.
Shankar T; Petrov AA
Curr Opin Allergy Clin Immunol; 2013 Feb; 13(1):19-24. PubMed ID: 23242113
[TBL] [Abstract][Full Text] [Related]
15. Omalizumab and other biologics in drug desensitization.
Fernandez J; Ruano-Zaragoza M; Blanca-Lopez N
Curr Opin Allergy Clin Immunol; 2020 Aug; 20(4):333-337. PubMed ID: 32398420
[TBL] [Abstract][Full Text] [Related]
16. Characterization of an anaphylactoid reaction to omalizumab.
Dreyfus DH; Randolph CC
Ann Allergy Asthma Immunol; 2006 Apr; 96(4):624-7. PubMed ID: 16680936
[TBL] [Abstract][Full Text] [Related]
17. Hypersensitivity to biological agents-updated diagnosis, management, and treatment.
Galvão VR; Castells MC
J Allergy Clin Immunol Pract; 2015; 3(2):175-85; quiz 186. PubMed ID: 25754718
[TBL] [Abstract][Full Text] [Related]
18. Desensitization protocol for rituximab-induced serum sickness.
Fajt ML; Petrov AA
Curr Drug Saf; 2014; 9(3):240-2. PubMed ID: 24861993
[TBL] [Abstract][Full Text] [Related]
19. Omalizumab-associated anaphylactic reactions reported between January 2007 and June 2008.
Lin RY; Rodriguez-Baez G; Bhargave GA
Ann Allergy Asthma Immunol; 2009 Nov; 103(5):442-5. PubMed ID: 19927545
[TBL] [Abstract][Full Text] [Related]
20. Rapid subcutaneous desensitization for the management of delayed hypersensitivity reactions to omalizumab：A case report.
Gan H; Wang L; Fu W; Zhang J; Yu M; Liu G
J Clin Pharm Ther; 2019 Jun; 44(3):486-488. PubMed ID: 30859588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
